- Home
- PROF vs INMB Comparison
PROF vs INMB Comparison
Compare PROF & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- INMB
- Stock Information
- Founded
- PROF N/A
- INMB 2015
- Country
- PROF Canada
- INMB United States
- Employees
- PROF N/A
- INMB N/A
- Industry
- PROF Medical/Dental Instruments
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- INMB Health Care
- Exchange
- PROF Nasdaq
- INMB Nasdaq
- Market Cap
- PROF 201.2M
- INMB 176.5M
- IPO Year
- PROF N/A
- INMB 2019
- Fundamental
- Price
- PROF $5.85
- INMB $7.59
- Analyst Decision
- PROF Strong Buy
- INMB Strong Buy
- Analyst Count
- PROF 1
- INMB 3
- Target Price
- PROF $12.00
- INMB $24.33
- AVG Volume (30 Days)
- PROF 65.7K
- INMB 259.4K
- Earning Date
- PROF 03-06-2025
- INMB 03-27-2025
- Dividend Yield
- PROF N/A
- INMB N/A
- EPS Growth
- PROF N/A
- INMB N/A
- EPS
- PROF N/A
- INMB N/A
- Revenue
- PROF $10,680,000.00
- INMB $14,000.00
- Revenue This Year
- PROF $165.23
- INMB N/A
- Revenue Next Year
- PROF $96.94
- INMB N/A
- P/E Ratio
- PROF N/A
- INMB N/A
- Revenue Growth
- PROF 48.35
- INMB N/A
- 52 Week Low
- PROF $4.75
- INMB $4.32
- 52 Week High
- PROF $11.42
- INMB $12.72
- Technical
- Relative Strength Index (RSI)
- PROF 29.08
- INMB 45.72
- Support Level
- PROF $4.75
- INMB $7.07
- Resistance Level
- PROF $7.15
- INMB $7.94
- Average True Range (ATR)
- PROF 0.47
- INMB 0.65
- MACD
- PROF -0.12
- INMB -0.05
- Stochastic Oscillator
- PROF 43.14
- INMB 29.32
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.